Induction of molecular remission by using anti-CC-chemokine receptor 4 (anti-CCR4) antibodies for adult T cell leukemia: a risk of opportunistic infection after treatment with anti-CCR4 antibodies

詳細情報 詳細情報について

• CRID

  1360855569786461056

• DOI

  10.1007/s00277-013-1765-6

• ISSN

  14320584

  09395555

• Web Site

  https://link.springer.com/content/pdf/10.1007/s00277-013-1765-6.pdf

  https://link.springer.com/article/10.1007/s00277-013-1765-6/fulltext.html

  http://link.springer.com/content/pdf/10.1007/s00277-013-1765-6

• データソース種別

  • Crossref